Announcing The New Flinders Fertility Medical Director

Announcing The New Flinders Fertility Medical Director



Flinders Fertility has announced the appointment of Professor Neil Johnson as its new Medical Director replacing Dr Enzo Lombardi who is retiring after 32 years at the unit.

CEO Lee Battye has welcomed Prof Johnson’s appointment:

“Neil has been with us since March this year and has quickly become a key member of staff, with us benefitting from his extensive knowledge and research interests. His promotion to Medical Director will enable us to continue our growth and offer patients access to world-leading care. “

“I’d like to thank our outgoing Medical Director, Dr Enzo Lombardi who is retiring after over three decades at Flinders Fertility. In his time at Flinders Fertility, he has helped bring hundreds of babies into the world and gave so many South Australians the family they dreamed of.  As he heads into retirement and on behalf of the whole team, I would like to thank him for his unwavering support of Flinders Fertility and say that we will miss him so much.”

Prof Johnson said: “Flinders Fertility was responsible for South Australia’s first IVF baby in 1982 and I’m delighted to be part of the organisation’s future. Enzo leaves big shoes to fill, but I'm eager to take on the challenge. During my time here I’ve seen how much the clinicians, nurses, counsellors, scientists, and admin work together to get the best outcomes for patients."

Professor Johnson is a specialist Gynaecologist who also holds a sub-specialty qualification in Reproductive Endocrinology and Infertility (CREI). Hailing from the UK where he qualified in Medicine, Prof Johnson is a fellow of both the UK and A/NZ Colleges of Obstetricians and Gynaecologists. 

Professor Johnson is a leading world expert in the diagnosis and treatment of endometriosis and served as President of The World Endometriosis Society from 2017 to 2021. His research interests include the fertility aspects of endometriosis (for which he has pioneered the use of Lipiodol in A/NZ), and polycystic ovarian syndrome (PCOS), with a special focus on evidence-based treatments for infertility.

Prof Johnson will commence as Medical Director on 18 December.